Skip to content
Open access

Polygenic risk score for early identification of coronary artery disease in a real-world clinical setting within the Latvian patient population

Aug 2026 · American Heart Journal Plus: Cardiology Research and Practice · Vol 70 · 0 citations · 29 references
Medicine

TL;DR

Investigating the utility of genome-wide association study - derived PRS and pathway-specific PRS in the Latvian population and demonstrating superior discrimination compared to pathway-specific PRS found incorporation of PRS enhances early-onset CAD risk prediction.

Abstract

Study objective Polygenic risk scores (PRS) are increasingly recognized for their potential to improve coronary artery disease (CAD) prediction beyond traditional clinical models. This study evaluated the utility of genome-wide association study (GWAS) - derived PRS and pathway-specific PRS (PS-PRS) in the Latvian population, aiming to assess their association with CAD and compare their predictive performance with conventional risk factors. Design, participants and main outcome measures The study included 90 early-onset CAD patients and 43 controls with no evidence of atherosclerotic lesions on coronary angiography, with next-generation sequencing performed. PRS was calculated using 192 single nucleotide variants identified from the CARDIoGRAMplusC4D GWAS meta-analysis. The predictive accuracy of PRS, PS-PRS, clinical risk factors, and their combinations was analyzed via ROC curves. Results The average age was 48.7 years in CAD patients and 49.8 in controls. CAD patients showed significantly higher PRS (mean 0.31) compared to controls (mean − 0.65; p < 0.0001). PRS alone had moderate discriminatory power (AUC = 0.773), slightly lower than LDL cholesterol (AUC = 0.775) and total cholesterol (AUC = 0.821). Combining clinical risk factors improved prediction (AUC = 0.872), with the highest accuracy when PRS was integrated with all clinical factors (AUC = 0.933). The PRS distributions were significantly elevated in early-onset CAD patients across the angiogenesis/tissue repair pathway (p = 0.00038), inflammation pathway (p = 0.043), vascular remodelling pathway (p = 0.0116), and pathway of genes with unknown function in atherosclerosis (p = 0.0035), but overall PRS demonstrated superior discrimination compared to pathway-specific PRS. Conclusions Incorporating PRS enhances early-onset CAD risk prediction. Pathway specific PRS had lower discriminative ability than the overall PRS.

Read PDF

Similar papers

Open access Sep 2026

Comparison of Performance of Publicly Available Polygenic Risk Scores to Predict Clinically Actionable Coronary Artery Calcium Scores: The BioHEART-CT Cohort.

AIM Coronary artery disease (CAD) remains the leading cause of morbidity and mortality globally. Polygenic Risk Scores (PRS) have been trained against major adverse cardiovascular outcomes (MACE) in large cohorts. Few studies have examined the effectiveness of these CAD MACE PRS tools in detecting individuals with subc...

M. Gray, D. Strbenac, Daniel Brieger et al. · 0 citations
Open access Oct 2026

Detection of High-Risk Pathogenic Alleles for Young-Onset Myocardial Infarction in a Malaysian Cohort: A Pilot Study

INTRODUCTION: Identifying pathogenic genetic variants associated with young-onset myocardial infarction (YOMI) may facilitate early risk stratification and enable timely preventive intervention. This pilot study aimed to compare the genetic profiles of patients with YOMI with healthy controls to identify high-risk gene...

H. Sani, T. Kek, Mohd Nur Fakhruzzaman Noorizhab et al. · 0 citations
Open access Sep 2026

Polygenic Risk Scores of Coronary Heart Disease in Chronic Kidney Disease Population: The CRIC Study.

BACKGROUND Cardiovascular disease is a major cause of death in individuals with chronic kidney disease; thus, improving its prediction is critical for cardiovascular disease risk reduction. Studies have not assessed whether a polygenic risk score (PRS) of coronary heart disease (CHD) developed from genetic studies in t...

Quan Sun, Amarnath Marthi, Jia Wen et al. · 0 citations
Sep 2026

The Impacts of MTHFR C677T Variant (rs1801133) on Cardiometabolic Profiles and Early Onset Coronary Artery Disease: A Case–Control Study

Background: The MTHFR C677T polymorphism (rs1801133) is a well-documented genetic variant in cardiovascular research, yet its mechanistic role in early onset coronary artery disease (EOCAD) remains poorly characterized in East Asian populations. This study aimed to explore whether rs1801133 modulates EOCAD risk by alte...

Gui-Qing Wang, Sheng-Ping Wang, Hang Li et al. · 0 citations
Conference Open access 2026

Population-Specific Coronary Artery Disease Genetic Risk Stratification in South Asians: Quantitative Evidence Synthesis and a Precision-Medicine Validation Framework

Background: Coronary artery disease (CAD) occurs at a particularly high and often early burden in South Asian populations, yet many genetic risk models used in cardiovascular research were derived mainly from European-ancestry cohorts. Objectives: This review examines a six-variant candidate panel for South-Asian CAD r...

A. Mohammed, Rami M. Alkhaleeli, M. Mustak et al. · 0 citations
Review Oct 2026

Polygenic Risk Scores: Towards Clinical Application.

The current state of bench-to-bedside translation of polygenic risk scores (PRS) is reviewed and it is shown that quality standards must be established to ensure that the potential of PRS can be effectively translated into routine clinical practice.

Johannes Schumacher, V. Koch, C. Maj et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.